Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2805-2820

  Affara, Nesrine I ^a   Trempus, Carol S ^d   Schanbacher, Brandon L ^e   Pei, Ping ^b   Mallery, Susan R ^b,c   Bauer, John A ^e   Robertson, Fredika M ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Akt; Bulge region; CD34; Cytokeratin 15; Hair follicle; Keratinocytes; Mammalian target of rapamycin (mTOR); Niche; Papilloma; Protein kinase B; Skin carcinogenesis; Stem cells

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN K15; PROTEIN KINASE B; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASAL CELL; CELL PROLIFERATION; CONFOCAL MICROSCOPY; HAIR FOLLICLE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE TEST; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SKIN CARCINOGENESIS; STEM CELL;

ANIMALS; ANTIGENS, CD34; CELL GROWTH PROCESSES; ENZYME ACTIVATION; FEMALE; HAIR FOLLICLE; KERATINOCYTES; MICE; MICE, INBRED SENCAR; PAPILLOMA; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STEM CELLS;

EID: 33746681251     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Cotsarelis G, Sun TT and Lavker RM: Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61: 1329-1337, 1990.
2. Morris RJ and Potten CS: Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen. J Invest Dermatol 112: 470-475, 1999.
3. Morris RJ, Fischer SM and Slaga TJ: Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol 84: 277-281, 1985.
4. Bickenbach JR and Chism E: Selection and extended growth of murine epidermal stem cells in culture. Exp Cell Res 244: 184-195, 1998.
5. Mackenzie IC and Bickenbach JR: Label-retaining keratinocytes and Langerhans cells in mouse epithelia. Cell Tissue Res 242: 551-556, 1985.
6. Bickenbach JR: Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res 60: 1611-1620, 1981.
7. Braun KM, Niemann C, Jensen UB, Sundberg JP, Silva-Vargas V and Watt FM: Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 130: 5241-5255, 2003.
8. Kaur P: Interfollicular epidermal stem cells: identification, challenges, potential. J Invest Dermatol, in press, 2006.
9. Potten CS: The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet 7: 77-88, 1974.
10. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M and Fuchs E: Defining the epithelial stem cell niche in skin. Science 303: 359-363, 2004.
11. Kobayashi K, Rochat A and Barrandon Y: Segregation of keratinocyte colony-forming cells in the bulge of the rat vibrissa. Proc Natl Acad Sci USA 90: 7391-7395, 1993.
12. Cotsarelis G, Kaur P, Dhouailly D, Hengge U and Bickenbach J: Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol 8: 80-88, 1999.
13. Morris RJ, Tacker KC, Fischer SM and Slaga TJ: Quantitation of primary in vitro clonogenic keratinocytes from normal adult murine epidermis, following initiation, and during promotion of epidermal tumors. Cancer Res 48: 6285-6290, 1988.
14. Morris RJ and Potten CS: Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif 27: 279-289, 1994.
15. Blanpain C, Lowry WE, Geoghegan A, Polak L and Fuchs E: Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118: 635-648, 2004.
16. Trempus CS, Morris RJ, Bortner CD, Cotsarelis G, Haircloth RS, Reece JM and Tennant RW: Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 120: 501-511, 2003.
17. Nickoloff BJ: The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127: 523-529, 1991.
18. Morris RJ, Liu Y, Maries L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA and Cotsarelis G: Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22: 411-417, 2004.
19. Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S and Cotsarelis G: The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 111(Pt 21): 3179-3188, 1998.
20. Krause DS, Fackler MJ, Civin CI and May WS: CD34: structure, biology, and clinical utility. Blood 87: 1-13, 1996.
21. Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, Sharkis SJ and May WS: Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84: 691-701, 1994.
22. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC and Vogel JC: Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 116: 249-260, 2006.
23. Cotsarelis G: Gene expression profiling gets to the root of human hair follicle stem cells. J Clin Invest 116: 19-22, 2006.
24. Liu Y, Lyle S, Yang Z and Cotsarelis G: Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol 121: 963-968, 2003.
25. Li A, Simmons PJ and Kaur P: Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 95: 3902-3907, 1998.
26. Tani H, Morris RJ and Kaur P: Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 97: 10960-10965, 2000.
27. Watt FM: Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21: 3919-3926, 2002.
28. Sonnenberg A, Calafat J, Janssen H, Daams H, van der Raaij-Helmer LM, Falcioni R, Kennel SJ, Aplin JD, Baker J, Loizidou M et al: Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 113: 907-917, 1991.
29. Jones PH, Harper S and Watt FM: Stem cell patterning and fate in human epidermis. Cell 80: 83-93, 1995.
30. Jones PH and Watt FM: Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713-724, 1993.
31. Lavker RM and Sun TT: Epidermal stem cells: properties, markers, and location. Proc Natl Acad Sci USA 97: 13473-13475, 2000.
32. Stenn KS and Cotsarelis G: Bioengineering the hair follicle: fringe benefits of stem cell technology. Curr Opin Biotechnol 16: 493-497, 2005.
33. Ito M, Kizawa K, Hamada K and Cotsarelis G: Hair follicle stem cells in the lower bulge form the secondary germ, a biochemically distinct but functionally equivalent progenitor cell population, at the termination of catagen. Differentiation 72: 548-557, 2004.
34. Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ and Cotsarelis G: Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 11: 1351-1354, 2005.
35. Ghazizadeh S and Taichman LB: Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J 20: 1215-1222, 2001.
36. Burgering BM and Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995.
37. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
38. James SR, Downes CP, Gigg R, Grove SJ, Holmes AB and Alessi DR: Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem J 315(Pt 3): 709-713, 1996.
39. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D, McCormick F, Feng J and Tsichlis P: Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17: 313-325, 1998.
40. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216, 1998.
41. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R and Dedhar S: Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374-22378, 2003.
42. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB and Cohen P: Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269, 1997.
43. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG and Hay N: Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365, 2003.
44. Affara NI, Schanbacher BL, Mihm MJ, Cook AC, Pei P, Mallery SR, Trempus CS, Bauer JA and Robertson FM: Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis. Anticancer Res 24: 2773-2781, 2004.
45. Faridi J, Fawcett J, Wang L and Roth RA: Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. Am J Physiol Endocrinol Metab 285: E964-972, 2003.
46. Nave BT, Ouwens M, Withers DJ, Alessi DR and Shepherd PR: Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2: 427-431, 1999.
47. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM and Abraham RT: A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60: 3504-3513, 2000.
48. Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC and Thomas G: Mammalian TOR: a homeostatic ATP sensor. Science 294: 1102-1105, 2001.
49. Proud CG: Regulation of mammalian translation factors by nutrients. Eur J Biochem 269: 5338-5349, 2002.
50. Fingar DC and Blenis J: Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23: 3151-3171, 2004.
51. Xu Q, Thompson JE and Carroll M: mTOR regulates cell survival after etoposide treatment in primary AML cells. Blood 106: 4261-4268, 2005.
52. Takuwa N, Fukui Y and Takuwa Y: Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol 19: 1346-1358, 1999.
53. Grewe M, Gansauge F, Schmid RM, Adler G and Seufferlein T: Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res 59: 3581-3587, 1999.
54. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W, Birek C and Boukamp P: Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene, in press, 2006.
55. Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, Garcia-Escudero R, Martinez-Cruz AB, Martinez-Palacio J, Hernandez P, Ballestin C and Paramio JM: Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25: 1174-1185, 2006.
56. Yamamoto H, Ochiya T, Takeshita F, Toriyama-Baba H, Hirai K, Sasaki H, Sakamoto H, Yoshida T, Saito I and Terada M: Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation. Cancer Res 62: 1641-1647, 2002.
57. Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG and Robertson FM: Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Mol Carcinog 7: 238-248, 1993.
58. Barrandon Y and Green H: Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302-2306, 1987.
59. Di-Poi N, Ng CY, Tan NS, Yang Z, Hemmings BA, Desvergne B, Michalik L and Wahli W: Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. Mol Cell Biol 25: 1696-1712, 2005.
60. Kim SJ, Cheon SH, Yoo SJ, Kwon J, Park JH, Kim CG, Rhee K, You S, Lee JY, Roh SI and Yoon HS: Contribution of the PI3K/Akt/PKB signal pathway to maintenance of self-renewal in human embryonic stem cells. FEBS Lett 579: 534-540, 2005.
61. Paling NR, Wheadon H, Bone HK and Welham MJ: Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279: 48063-48070, 2004.
62. Alonso L, Okada H, Pasolli HA, Wakeham A, You-Ten AI, Mak TW and Fuchs E: Sgk3 links growth factor signaling to maintenance of progenitor cells in the hair follicle. J Cell Biol 170: 559-570, 2005.
63. Morris RJ: A perspective on keratinocyte stem cells as targets for skin carcinogenesis. Differentiation 72: 381-386, 2004.
64. Morris RJ, Coulter K, Tryson K and Steinberg SR: Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res 57: 3436-3443, 1997.
65. Thrash BR, Menges CW, Pierce RH and McCance DJ: AKT1 provides an essential survival signal required for differentiation and stratification on primary human keratinocytes. J Biol Chem 281: 12155-12162, 2006.
66. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB and Thomas G: Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16: 3693-3704, 1997.
67. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C and Blenis J: mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24: 200-216, 2004.
68. Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr and Sonenberg N: Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371: 762-767, 1994.
69. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I and Avruch J: Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 272: 26457-26463, 1997.
70. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr and Abraham RT: Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15: 5256-5267, 1996.
71. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N and Lawrence JC Jr: PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266: 653-656, 1994.
72. Robles AI and Conti CJ: Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 16: 781-786, 1995.
73. Celis JE and Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 82: 3262-3266, 1985.
74. Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV, Martinez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL and Paramio JM: Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21: 53-64, 2002.